965140

Ajanta Pharma USA Inc — FEI 3010721419

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 17, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgewater, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683021 CFR 314.80(c)(2)Interval
683121 CFR 314.80(c)(2)Late submission of quarterly safety reports
891221 CFR 314.81(b)(2)Timely submission